Differences of two cryoballoon generations: Insights from the prospective multicentre, multinational FREEZE Cohort Substudy

Europace

Volumn 16, Issue 10, 2014, Pages 1434-1442

  Straube, Florian ^a   Dorwarth, Uwe ^a   Vogt, Juergen ^b   Kuniss, Malte ^c   Kuck, Karl Heinz ^d   Tebbenjohanns, Juergen ^e   Alberola, Arcadi Garcia ^f   Chun, Kyoung Ryul Julian ^g   Souza, Joseph J ^h   Ouarrak, Taoufik ⁱ   Senges, Jochen ⁱ   Brachmann, Johannes ^j   Lewalter, Thorsten ^k   Hoffmann, Ellen ^a  

^a Munich Municipal Hospital   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c KERCKHOFF HEART CENTER   (Germany)

^d DEPARTMENT OF CARDIOLOGY   (Germany)

^e Angiology and Intensive Care   (Germany)

^f HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^g CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

^h Mission Hospital   (United States)

ⁱ IHF   (Germany)

^j KLINIKUM COBURG   (Germany)

^k ISAR Clinic Munich   (Germany)

more..

Author keywords

Ablation; Atrial fibrillation; Cryoballoon; Efficacy; Pulmonary vein isolation; Safety

Indexed keywords

ABLATION CATHETER; ABLATION THERAPY; ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CRYOBALLOON; CRYOBALLOON ABLATION; DEVICE SAFETY; FEMALE; FLUOROSCOPY; HEART DISEASE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAPPING CATHETER; MULTICENTER STUDY; PAROXYSMAL ATRIAL FIBRILLATION; PHRENIC NERVE PARALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VEIN ISOLATION; RADIOFREQUENCY ABLATION; RECURRENCE RISK; ATRIAL FIBRILLATION; CATHETER ABLATION; CLINICAL TRIAL; CRYOSURGERY; DEVICES; ECHOCARDIOGRAPHY; ECHOGRAPHY; MIDDLE AGED; OPERATION DURATION; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PROCEDURES; PULMONARY VEIN; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; CRYOSURGERY; ECHOCARDIOGRAPHY; FEMALE; FLUOROSCOPY; HUMANS; MALE; MIDDLE AGED; OPERATIVE TIME; PATIENT SAFETY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PULMONARY VEINS; TREATMENT OUTCOME;

EID: 84926676443     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu162     Document Type: Article

References (27)

1. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114: 119-25.
2. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ et al.Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014;129:837-47.
3. WilkeT, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace 2013;15:486-93.
4. Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib SM. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol 2009;2: 626-33.
5. Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol 2013;61: 1713-23.
6. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-413.
7. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. 2012 HRS/ EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606.
8. Andrade JG, Khairy P, Guerra PG, Deyell MW, Rivard L, Macle L et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm 2011;8:1444-51.
9. Andrade JG, Dubuc M, Guerra PG, Macle L, Mondesert B, Rivard L et al. The biophysics and biomechanics of cryoballoon ablation. Pacing Clin Electrophysiol 2012;35: 1162-8.
10. Vogt J, Heintze J, Gutleben KJ, Muntean B, Horstkotte D, Nolker G. Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients. J Am Coll Cardiol 2013;61:1707-12.
11. Dorwarth U, Schmidt M,Wankerl M, Krieg J, Straube F, Hoffmann E. Pulmonary vein electrophysiology during cryoballoon ablation as a predictor for procedural success. J Interv Card Electrophysiol 2011;32:205-11.
12. Namdar M, Chierchia GB,Westra S, Sorgente A, Meir ML, Bayrak F et al. Isolating the pulmonary veins as first-line therapy in patients with lone paroxysmal atrial fibrillation using the cryoballoon. Europace 2012;14:197-203.
13. Schmidt M, Dorwarth U, Andresen D, Brachmann J, Kuck KH, Kuniss M et al. Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry. J Cardiovasc Electrophysiol 2014;25:1-7.
14. Coulombe N, Paulin J, SuW. Improved in vivo performance of second-generation cryoballoon for pulmonary vein isolation. J Cardiovasc Electrophysiol 2013;24: 919-25.
15. Andrade JG, Dubuc M, Guerra PG, Landry E, Coulombe N, LeducHet al. Pulmonary vein isolation using a second-generation cryoballoon catheter: a randomized comparison of ablation duration and method of deflation. J Cardiovasc Electrophysiol 2013;24:692-8.
16. Furnkranz A, Bordignon S, Schmidt B, Gunawardene M, Schulte-Hahn B, Urban V et al. Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon. J Cardiovasc Electrophysiol 2013;24:492-7.
17. Straube F, Dorwarth U, Schmidt M,Wankerl M, Ebersberger U, Hoffmann E. Comparison of the first and second cryoballoon: high-volume single-center safety and efficacy analysis. Circ Arrhythm Electrophysiol 2014;7:293-9.
18. Chierchia GB, Di Giovanni G, Ciconte G, de Asmundis C, Conte G, Sieira-Moret J et al. Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: 1-year follow-up. Europace 2014;16:639-44.
19. Chierchia GB, Di Giovanni G, Sieira-Moret J, de Asmundis C, Conte G, Rodriguez-Manero M et al. Initial experience of three-minute freeze cycles using the second-generation cryoballoon ablation: acute and short-term procedural outcomes. J Interv Card Electrophysiol 2014;39:145-51.
20. Ho SY, Cabrera JA, Sanchez-Quintana D. Left atrial anatomy revisited. Circ Arrhythm Electrophysiol 2012;5:220-8.
21. Knecht S, Kuhne M, Altmann D, Ammann P, Schaer B, Osswald S et al. Anatomical predictors for acute and mid-term success of cryoballoon ablation of atrial fibrillation using the 28 mm balloon. J Cardiovasc Electrophysiol 2013;24:132-8.
22. SchmidtM,DorwarthU, Straube F,DaccarettM,Rieber J,WankerlMet al. Cryoballoon in AF ablation: impact of PV ovality on AF recurrence. Int J Cardiol 2013;167:114-20.
23. Metzner A, Burchard A, Wohlmuth P, Rausch P, Bardyszewski A, Gienapp C et al. Increased incidence of esophageal thermal lesions using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol 2013;6:769-75.
24. Furnkranz A, Bordignon S, Schmidt B, Bohmig M, Bohmer MC, Bode F et al. Luminal esophageal temperature predicts esophageal lesions after second-generation cryoballoon pulmonary vein isolation. Heart Rhythm 2013;10:789-93.
25. Andrade JG, Dubuc M, Ferreira J, Guerra PG, Landry E, CoulombeNet al. Histopathology of cryoballoon ablation-induced phrenic nerve injury. Journal of Cardiovascular Electrophysiology 2013;25:187-194.
26. Cappato R, Calkins H, Chen SA, DaviesW, Iesaka Y, Kalman J et al. Updated worldwide surveyon the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:32-8.
27. Leong-Sit P, Roux JF, Zado E, Callans DJ, Garcia F, Lin D et al. Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study. Circ Arrhythm Electrophysiol 2011;4:11-4.